Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - MIMEDX GROUP, INC. | ex321soxceo90620181231.htm |
EX-32.2 - EXHIBIT 32.2 - MIMEDX GROUP, INC. | ex322soxcfo90620181231.htm |
EX-31.2 - EXHIBIT 31.2 - MIMEDX GROUP, INC. | ex312soxcfo30220181231.htm |
EX-31.1 - EXHIBIT 31.1 - MIMEDX GROUP, INC. | ex311soxceo30220181231.htm |
EX-21.1 - EXHIBIT 21.1 - MIMEDX GROUP, INC. | ex211subsidiaries12312.htm |
EX-10.26 - EXHIBIT 10.26 - MIMEDX GROUP, INC. | ex1026hadenconsultinga.htm |
EX-10.19 - EXHIBIT 10.19 - MIMEDX GROUP, INC. | ex10192018mipcorrected.htm |
EX-10.16 - EXHIBIT 10.16 - MIMEDX GROUP, INC. | ex1016formofdirectorrs.htm |
EX-10.4 - EXHIBIT 10.4 - MIMEDX GROUP, INC. | exhibit104secondamendm.htm |
10-K - 10-K - MIMEDX GROUP, INC. | restated2016-2018annua.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Mimedx Group, Inc.
Marietta, Georgia
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8, (No. 333-153255, 333-183991, 333-189784, 333-199841, and 333-211900) of MiMedx Group, Inc. of our reports dated March 17, 2020
relating to the consolidated financial statements and financial statement schedule, and effectiveness of Mimedx Group, Inc's internal control over financial reporting which appear in this Form 10-K. Our report on the effectiveness of internal control over financial reporting expresses an adverse opinion on the effectiveness of MiMedx Group, Inc.’s internal control over financial reporting as of December 31, 2018.
/s/ BDO USA, LLP
Atlanta, Georgia
March 17, 2020